Early detection remains one of the biggest challenges in cancer care, particularly for ovarian cancer, where symptoms can be difficult to recognize and effective routine screening options remain limited. Mercy is addressing this gap t... Read more
The development of cannabinoid and psychedelic medicines is entering a more evidence-driven phase, with clinical validation, safety, regulatory alignment and patient outcomes becoming increasingly important to their potential adoption. For ... Read more
At INTERPHEX, sustainability and supply chain performance emerged as important priorities for pharmaceutical packaging. John Jansen, Head of Global Marketing and Intelligence at CurTec, discusses how packaging manufacturers can reduce material use an... Read more
As breast imaging continues to evolve toward more quantitative and patient-centred approaches, QT Imaging is developing a three-dimensional ultrasound platform designed to provide detailed breast imaging without ionising radiation, compressio... Read more
HCW Biologics Inc. (the “Company” or “HCW Biologics”), a U.S.-based clinical-stage biopharmaceutical company focused on developing novel fusion immunotherapeutics to treat autoimmune diseases, cancer, and senescence-associat... Read more
Eisai Co., Ltd. and Biogen Inc., announced that once weekly lecanemab-irmb subcutaneous injection (brand name: LEQEMBI IQLIK®) is now available in the U.S. for initiation therapy for early Alzheimer’s disease (AD) in adults with mild cogn... Read more
Lonza will build a new large-scale, commercial PSD-4 spray-drying facility in Bend, Oregon (US) to support a rapidly expanding market segment The investment will reinforce the Bend site as a center of excellence for particle engineering ... Read more
As AI and digital technologies increasingly influence pharmaceutical development, CDMOs are taking on a broader role in helping sponsors improve efficiency, manage risk and accelerate development timelines. In this interview, Matt Pat... Read more
© 2026 Biopharma Boardroom. All Rights Reserved.
